Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Clinical trial NCT00398073 · COMPLETED

Trial details

NCT number: NCT00398073
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 2006-10-01
Primary completion: 2011-03-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.